The biosimilar name debate: what's at stake for public health

被引：11

|

作者：

Alexander, Emily A. ^{[1
]}

机构：

[1] AbbVie Inc, US Regulatory Affairs, Biol Strateg Dev, Bldg AP31,1 North Waukegan Rd, N Chicago, IL 60064 USA

来源：

GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL | 2014年 / 3卷 / 01期

关键词：

Adverse event reporting; biosimilars; naming;

D O I：

10.5639/gabij.2014.0301.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：10 / 12

页数：3

相关论文

共 50 条

[11] WHAT'S AT STAKE FOR CONTENT CREATORS IN THE NET NEUTRALITY DEBATE?
Martin, Erik J.
[J]. ECONTENT, 2015, 38 (03) : 18 - 23
[12] WHAT IS AT STAKE IN THE DEBATE ON NONCONCEPTUAL CONTENT?
Bermudez, Jose Luis
[J]. PHILOSOPHICAL PERSPECTIVES, 2007, 21 (01) : 55 - 72
[13] From Community Genetics to Public Health Genomics - What's in a Name?
Knoppers, B. M.
Brand, A. M.
[J]. PUBLIC HEALTH GENOMICS, 2009, 12 (01) : 1 - 3
[14] The conventional status of reflexive awareness: What's at stake in a Tibetan debate?
Garfield, JL
[J]. PHILOSOPHY EAST & WEST, 2006, 56 (02): : 201 - +
[15] The public's stake in nonprofit health plan conversions
Sherry, ST
Seto, N
[J]. HEALTH AFFAIRS, 1996, 15 (02) : 317 - 317
[16] Sexual health: what's in a name?
Dillon, A
Anderson, B
Donovan, B
[J]. GENITOURINARY MEDICINE, 1997, 73 (04): : 323 - 323
[17] Education for Health: What's in a Name?
Glasser, M.
Pathman, D.
[J]. EDUCATION FOR HEALTH, 2010, 23 (02) : 520 - 521
[18] Public or private "ownership" - what's in a name?
Davis, J
Cashin, G
[J]. 3RD WORLD WATER CONGRESS: WATER SERVICES MANAGEMENT, OPERATIONS AND MONITORING, 2003, 3 (1-2): : 441 - 447
[19] What's at Stake in the Transition Debate? Rethinking the Origins of Capitalism and the 'Rise of the West'
Anievas, Alexander
Nisancioglu, Kerem
[J]. MILLENNIUM-JOURNAL OF INTERNATIONAL STUDIES, 2013, 42 (01): : 78 - 102
[20] The public's stake
Kass, LR
[J]. PUBLIC INTEREST, 2003, (150) : 38 - 41

← 1 2 3 4 5 →